techLIVE
NHS Trusts Dispute Palantir Benefits Claims, Medact Finds
NHS trusts dispute Palantir benefits claims, with 29 of the 137 trusts listed as benefiting saying they do not use the platform.
Key points
- 29 trusts listed by NHS England as benefiting from the Federated Data Platform told Freedom of Information responses they were not using it.
- The government must decide in December whether to continue the £330 million agreement with a Palantir-led consortium.
- NHS England awarded the FDP contract in November 2023, after contracts worth £60 million were awarded without competition during the
Why it matters. The government's December decision on the £330 million contract could depend on whether the disputed benefit claims hold up, while MPs press it on whether exit plans exist.
Twenty-nine NHS trusts listed as benefiting from Palantir's Federated Data Platform said in Freedom of Information responses that they were not using it, according to campaign group Medact. That is about 21 percent of the 137 trusts NHS England lists as realising benefits, while the government must decide in December whether to keep the £330 million deal. Palantir says the software has helped deliver 100,000 additional operations.
Latest updates
NHS Trusts Dispute Palantir Benefits Claims, Medact Finds
Twenty-nine NHS trusts listed as benefiting from Palantir's Federated Data Platform (FDP) said in Freedom of Information responses that they were not using it, according to the health worker campaign group Medact. That represents about 21 percent of the 137 trusts that NHS England lists as realising benefits from the platform. Medact flagged the discrepancies as the government considers whether to continue the contract, which is valued at £330 million. The disputed entries raise questions about how NHS England compiles its benefits data. The government has yet to decide on the deal's future.